Kentucky patients who are concerned about a urinary tract infection, flu or throat inflammation now have the opportunity to receive treatment and professional services related to these and many other illnesses from a pharmacist who acts under the direction of a prescribing physician. There must be a prescriber-approved protocol, based on current clinical guidelines, that meets the minimum requirements and has been approved by the Board of Pharmacy. In addition, the regulation provides that pharmacists must document that they have received training and training on the purpose of the protocol before starting treatment in accordance with the protocol. Similar to the distribution of naloxone, drugs dispensed under the protocol should be recorded in the dosing system, as requested in 201 KAR 2:170. In Kentucky, as in many countries, access to care is an important issue. The Healthcare Workforce Analysis of the Healthcare Resources and Services Administration estimates that Kentucky is expected to have a lack of suitability of nearly 30 percent of family physicians by 2025. Advanced pharmacy services as part of a CPA are called collaborative drug therapy management (CDM). [a] While the traditional field of activity of pharmacists provides the legal authority to detect drug-related problems (DRPs) and submit proposals to prescribers (e.g.B. physicians) to resolve DRPs, pharmacists who provide CDMs directly resolve DRPs when they recognize them. This may include prescribing activities that include the selection and initiation of drugs to treat a patient`s diagnosed diseases (as described in the CPA), discontinuation of prescription or non-prescription drugs, and modification of a patient`s drug treatment (e.g. starch modification, frequency, route of administration or duration of treatment), evaluation of a patient`s response to a drug ntöse therapy (which may include ordering and performing laboratory tests such as a basal metabolic panel) and continuing drug therapy (providing a new prescription).  The new authorities were part of a two-year effort to revise Kentucky`s Pharmacy Act with new protocols authorized by the board of directors.
The Kentucky legislature passed a law in 2016 and the accompanying regulation was approved in late 2017, allowing Kentucky pharmacists to provide certain services outlined in a particular care protocol. The regulation states that a pharmacist may initiate the distribution of uncontrolled or over-the-counter medications and associated professional services. In 2015, the American College of Clinical Pharmacy (ACCP) published an updated white paper on collaborative management of drug therapy. . . .